Categories
Analysis Forecast

Gene Therapy Market Research 2020 Report | Growth Forecast 2025

The Gene Therapy Market report provides a detailed analysis of the dynamic of the market with extensive focus on secondary research. The report sheds light on the current situation of the market size, share, demand, development patterns, and forecast in the coming years.

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The report Global Gene Therapy Market analyzes the strategy patterns, and forecast in the coming years. The report evaluates the market size of the Global Gene Therapy Market studies the strategy patterns adopted by the prominent international players. Also, the report evaluates the size of the market in terms of revenue for the forecast period. All the data figures like percentage shares, splits, and breakdowns are determined using secondary sources and verified through primary sources.

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/59028

The report highlights the key players and manufacturers and the latest strategies including new product launches, partnerships, joint ventures, technology, segmentation in terms of region and industry competition, profit and loss ration, and investment ideas. A precise evaluation of effective manufacturing techniques, advertisement techniques, market share size, growth rate, size, revenue, sales and value chain analysis.

Key Competitors of the Global Gene Therapy Market are:
,Kite Pharma,BioVex,Novartis,Spark Therapeutics,, ,

The ‘Global Gene Therapy Market Research Report’ is a comprehensive and informative study on the current state of the Global Gene Therapy Market industry with emphasis on the global industry. The report presents key statistics on the market status of the global Gene Therapy market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Major Product Types covered are:

Ex Vivo
In Vivo

Major Applications of Gene Therapy covered are:

Cancer Diseases
Hematological Disease
Hereditary Disease

To get this report at a profitable rate.: https://reportsinsights.com/discount/59028

Regional Gene Therapy Market (Regional Output, Demand & Forecast by Countries):-
North America (United States, Canada, Mexico)
South America ( Brazil, Argentina, Ecuador, Chile)
Asia Pacific (China, Japan, India, Korea)
Europe (Germany, UK, France, Italy)
Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And More.

The research report studies the past, present, and future performance of the global market. The report further analyzes the present competitive scenario, prevalent business models, and the likely advancements in offerings by significant players in the coming years.

Important Features of the report:
– Detailed analysis of the Global Gene Therapy market
–Fluctuating market dynamics of the industry
–Detailed market segmentation
– Historical, current and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of the Global Gene Therapy Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth
– A neutral perspective towards Global Gene Therapy market performance

Access full Report Description, TOC, Table of Figure, Chart, etc. @   https://reportsinsights.com/industry-forecast/Gene-Therapy-Market-Global-Opportunity-59028

Reasons to Purchase Global Gene Therapy Market Report:
1. Current and future of Global Gene Therapy market outlook in the developed and emerging markets.
2. Analysis of various perspectives of the market with the help of Porter’s five forces analysis.
3. The segment that is expected to dominate the Global Gene Therapy market.
4. Regions that are expected to witness the fastest growth during the forecast period.
5. Identify the latest developments, Global Gene Therapy market shares, and strategies employed by the major market players.

Besides, the market study affirms the leading players worldwide in the Global Gene Therapy market. Their key marketing strategies and advertising techniques have been highlighted to offer a clear understanding of the Global Gene Therapy market.

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

 : (US) +1-214-272-0234

 : (APAC) +91-7972263819

Email: [email protected]

Sales: [email protected]

 

Categories
Market Reports Market Study News

Gene Therapy Market Industry Growth With High CAGR During Forecast 2020 | Covid-19 Impact

The Business Research Company’s Gene Therapy Market Global Report 2020-30: Covid 19 Growth and Change. The report covers market size, key players, market share and trends to 2030.

Gene Therapy Market Global Report 2020-30: Covid 19 Growth and Change is one of a series of new reports from The Business Research Company that provide Gene Therapy market overviews, analyze and forecast market size and growth for the whole market, Gene Therapy market segments and geographies, Gene Therapy market trends, Gene Therapy market geographies. The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read More On The Gene Therapy Market Here –
https://www.thebusinessresearchcompany.com/report/gene-therapy-market-global-report-2020-30-covid-19-growth-and-change

The gene therapy market consists of sales of gene therapy related services by entities (organizations, sole traders and partnerships) that manufacture gene therapy drugs. Gene therapy is used to replace faulty genes or add new genes to cure disease or improve the body`s ability to fight disease. Only goods and services traded between entities or sold to end consumers are included.

Request A Sample For The Gene Therapy Market Report Now –
https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

The global gene therapy market is expected to decline from $3.22 billion in 2019 to $3.18 billion in 2020 at a compound annual growth rate (CAGR) of -1.30%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The market is then expected to recover and reach $6.84 billion in 2023 at a CAGR of 29.09%.

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_Info

Categories
News

Gene Therapy Market gaining traction due to new market developments, says Polaris Analysts

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

 

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

 

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
News

Gene Therapy Market gaining traction due to new market developments, says Polaris Analysts

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

 

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

 

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
Analysis Forecast Market Price Analysis Market Reports Market Size

Gene Therapy Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
News

Gene Therapy Market is Projected to Expand at a CAGR of 40.0% from 2018 to 2026

Transparency Market Research (TMR) has published a new report titled, “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global gene therapy market was valued at US$ 17.0 Mn in 2017 and is projected to expand at a CAGR of 40.0% from 2018 to 2026. New product approvals, promising therapeutic outcomes of gene therapy, and high prevalence of non-Hodgkin Lymphoma are anticipated to drive the global market in the next few years. Europe is projected to dominate the global gene therapy market, followed by U.S., by the end of 2026. Potential unmet needs in the fields of oncology, rare genetic disorders in the U.S. and Europe, new product approvals and commercialization, and high clinical R&D budgets are likely to drive the gene therapy market in these regions during the forecast period. The gene therapy market in Rest of World is projected to expand at a significant CAGR during the forecast period. The high growth rate is attributed to the anticipated approval and commercialization of gene therapy products in developed countries such as Japan, Australia & New Zealand, GCC countries, and China, and high prevalence of non-Hodgkin Lymphoma and head and neck cancers.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1838

New product approvals & commercialization drives market

2016, 2017, and 2018 were key milestones in the history of the gene therapy market in the U.S. and Europe, as around four gene therapy products have been approved and commercialized. These products are currently in the infancy stage of commercialization, and have exhibited highly positive therapeutic outcomes. For instance, in May 2016, GlaxoSmithKline (GSK) gene therapy product, Strimvelis, received marketing approval for the treatment of patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency, due to Adenosine Deaminase deficiency). Strimvelis is the first ex-vivo stem cell gene therapy to be approved in Europe for the treatment of ADA-SCID. Furthermore, in August 2017, the USFDA approved Novartis AG’s flagship gene therapy product, Kymriah, for the treatment of children and adults up to the age of 25 years affected with B-cell precursor acute lymphoblastic leukemia (ALL). Thus, recent approvals of gene therapy products in the U.S. and Europe for the treatment of various life threatening disorders is projected to fuel the gene therapy market during the forecast period.

Yescarta to be highest revenue generating gene therapy product

The report offers a detailed segmentation of the global gene therapy market based on different gene therapy products approved and commercialized. Based on product, the global gene therapy market has been segmented into Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine. Yescarta (Axicabtagene Ciloleucel) is a genetically modified autologous Chimeric Antigen Receptor T (CAR T) cell immunotherapy developed by Gilead Sciences, Inc. for the treatment of adult patients with relapsed or refractory large B-cell lymphoma including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL). It is the first CAR T therapy approved by the US FDA for the treatment of DLBCL. The Yescarta segment is projected to dominate the global gene therapy market by the end of 2026. Anticipated commercialization of Yescarta in Europe and other developed countries and increasing number of treatment centers are key factors that are likely to lead to the dominant share held by Yescarta by the end of 2026.

Request for Analysis of COVID19 Impact on Gene Therapy Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1838

Oncology segment to account for high market share

In terms of application, the global gene therapy market has been segmented into ophthalmology, oncology, and adenosine deaminase ?deficient severe combined immunodeficiency (ADA-SCID). The oncology segment is likely to account for a significant share of the market by the end of 2026. Oncology is a highly studied medical field in the clinical pipeline studies of gene therapy candidates. More than 60% of gene therapy clinical research studies are focused on oncology. The large share held by the oncology segment is attributed to the approval and commercialization of Yescarta and Kymriah, in the last one to two years, for the treatment of certain types of non-Hodgkin lymphoma in the U.S. and Europe. Furthermore, increase in demand for Gendicine in China for the treatment of head and neck cancers is projected to drive the segment during the forecast period.

Europe offers high incremental opportunity

The gene therapy market in Europe is projected to expand at a significant CAGR of 30.6% during the forecast period. Large number of patient population with refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), promising therapeutic outcomes, rising demand for gene therapy treatment, and increasing number of gene therapy treatment centers in Europe are key factors that are likely to fuel the gene therapy market in Europe. Moreover, different pricing models are being evaluated by payers and governments to enable access to high priced gene therapy products. This is likely to drive the demand for gene therapy products in Europe during the forecast period.

Purchase Gene Therapy Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=1838&ltype=S

Large number of clinical pipeline studies and significant investments in gene therapy to gain the first mover advantage

The global gene therapy market is highly consolidated, with very few global players accounting for a major share. Currently, only five companies; Gilead life Sciences Inc. Spark Therapeutic Inc., Novartis AG, Sibiono GeneTech Co. Ltd, and Orchard Therapeutics Limited offer gene therapy products in the market. Most biopharmaceutical companies have invested significantly in clinical R&D for the development of gene therapy products for different chronic and genetic disorders. Large number of gene therapy products are under different stages of clinical pipeline studies, and the number of gene therapy candidates is projected to rise consistently during the forecast period. For instance, according to the Journal of Gene Medicine, there were around 2,597 gene therapy candidates under clinical trials, as of 2017. Of the total clinical studies, around 65% of studies were focused on oncology, 11% of studies were focused on monogenetic field, 7% on infectious diseases and cardiovascular disease, each.

More Trending Reports by Transparency Market Research –

Fetal Monitoring Systems Market: https://www.prnewswire.com/news-releases/innovation-in-wearable-devices-driving-fetal-monitoring-systems-market-to-upward-growth-trajectory-tmr-301015185.html

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Categories
Analysis Forecast Coronavirus COVID-19 Industry Impact Market Size

Gene Therapy Market Future Forecast Assessed On The Basis Of How The Market Is Predicted To Grow

According to a new report published by Polaris Market Research, the global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need.

Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

Request for sample copy of this report @  https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.

Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Request for Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us

Mr. Likhil

Corporate Sales, USA

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
News

Gene Therapy Market 2020 Industry Share, Manufacturing Size, Driving Factors with Top Manufacturers, Trends and Forecast to 2026

Sangamo_tagg

Global ”Gene Therapy Market” report provides detailed market segment level data on the international market. The report addresses forecast and growth factor, regions, type and application. The Gene Therapy market report introduce incorporates analysis of definitions, classifications, applications and industry chain structure. Besides this, the Gene Therapy industry report also consists of development trends, competitive landscape analysis, and key regions development status.

Get a Sample Copy of the Report – http://www.industryresearch.co/enquiry/request-sample/14528734

Top Key Manufacturers in Gene Therapy Market Report:

  • Sangamo
  • Celladon
  • Spark Therapeutics
  • Dimension Therapeutics
  • Advantagene
  • Avalanche Bio
  • UniQure NV
  • Shanghai Sunway Biotech Co. Ltd
  • Bluebird Bio
  • Sibiono GeneTech

    For More Information or Query or Customization Before Buying, Visit at  http://www.industryresearch.co/enquiry/pre-order-enquiry/14528734

    Gene Therapy Market Data by Type

  • Viral vector
  • Non-viral vector
  • Gene Therapy Market Data by Application:

  • Oncological Disorders
  • Rare Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Infectious disease
  • Other Diseases
  • Some of the Key Questions Answered in this Report:

    • Detailed Overview of Gene Therapy market size will help deliver clients and businesses making strategies.
    • Influencing factors that thriving demand and latest trend running in the market.
    • Gene Therapy Market forecast for both the market as entire and split into segments, like region, product, applications, end-use, technology, etc.
    • What trends, challenges and barriers will impact the development and sizing of the Global market report?
    • SWOT Analysis of each defined key players along with its profile and Porter’s five forces tool mechanism to compliment the same.
    • What is the Gene Therapy market growth momentum or acceleration market carries during the forecast period?

    Geographical Regions covered in Gene Therapy market report are North America, Europe, Asia-Pacific, South America, Middle East, Southeast Asia, and Africa. Further, divided into countries as United States, Canada Mexico, Germany, France, UK, Russia, Italy, China, Japan, Korea, India, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Egypt, Nigeria, South Africa, and Others.

    Reasons to buy this report:

    • Identify the latest developments, market shares and strategies employed by the major market players.
    • Analysing various perspectives of the market with the help of Porter’s five forces analysis
    • Study on the product type and application expected to dominate the market.
    • Study on the country expected to witness fastest growth during the forecast period.
    • Forecasts the market value by assessing the impact of market drivers and constraints.

    Purchase this Report (Price 3960 USD for a Single-User License) – http://www.industryresearch.co/purchase/14528734

    Gene Therapy Market TOC Covers the Following Points:

    1 Market Overview

    1.1 Gene Therapy Introduction

    1.2 Market Analysis by Type

    1.3 Market Analysis by Application

    1.4 Market Analysis by Region

    1.4.1 United States Market States and Outlook (2014-2026)

    1.4.2 Europe Market States and Outlook (2014-2026)

    1.4.3 China Market States and Outlook (2014-2026)

    1.4.4 Japan Market States and Outlook (2014-2026)

    1.4.5 Southeast Asia Market States and Outlook (2014-2026)

    1.4.6 India Market States and Outlook (2014-2026)

    1.4.7 Brazil Market States and Outlook (2014-2026)

    1.4.8 GCC Countries Market States and Outlook (2014-2026)

    1.5 Market Dynamics and Development

    1.5.1 Merger, Acquisition and New Investment

    1.5.2 Market SWOT Analysis

    1.5.3 Drivers

    1.5.4 Limitations

    1.5.5 Opportunities and Development Trends

    1.6 Global Gene Therapy Market Size Analysis from 2014 to 2026

    1.6.1 Global The Market Size Analysis from 2014 to 2026 by Consumption Volume

    1.6.2 Global The Market Size Analysis from 2014 to 2026 by Value

    1.6.3 Global The Price Trends Analysis from 2014 to 2026

    2 Global Gene Therapy Competition by Types, Applications, and Top Regions and Countries

    2.1 Global (Volume and Value) by Type

    2.1.1 Global Consumption and Market Share by Type (2014-2019)

    2.1.2 Global Revenue and Market Share by Type (2014-2019)

    2.2 Global (Volume and Value) by Application

    2.2.1 Global Consumption and Market Share by Application (2014-2019)

    2.2.2 Global Revenue and Market Share by Application (2014-2019)

    2.3 Global (Volume and Value) by Region

    2.3.1 Global Consumption and Market Share by Region (2014-2019)

    2.3.2 Global Revenue and Market Share by Region (2014-2019)

    3 United States Market Analysis

    3.1 Consumption and Value Analysis

    3.2 Consumption Volume by Type

    3.3 Consumption Structure by Application

    4 Europe Gene Therapy Market Analysis

    4.1 Consumption and Value Analysis

    4.2 Consumption Volume by Type

    4.3 Consumption Structure by Application

    4.4 Consumption by Top Countries

    4.4.1 Germany Gene Therapy Consumption Volume from 2014 to 2019

    4.4.2 UK Gene Therapy Consumption Volume from 2014 to 2019

    4.4.3 France Gene Therapy Consumption Volume from 2014 to 2019

    4.4.4 Italy Gene Therapy Consumption Volume from 2014 to 2019

    4.4.5 Spain Gene Therapy Consumption Volume from 2014 to 2019

    4.4.6 Poland Gene Therapy Consumption Volume from 2014 to 2019

    4.4.7 Russia Gene Therapy Consumption Volume from 2014 to 2019

    5 China The Market Analysis

    5.1 Consumption and Value Analysis

    5.2 Consumption Volume by Type

    5.3 Consumption Structure by Application

    6 Japan Gene Therapy Market Analysis

    6.1 Consumption and Value Analysis

    6.2 Consumption Volume by Type

    6.3 Consumption Structure by Application

    7 Southeast Asia Gene Therapy Market Analysis

    7.1 Consumption and Value Analysis

    7.2 Consumption Volume by Type

    7.3 Consumption Structure by Application

    7.4 Consumption by Top Countries

    7.4.1 Consumption Volume from 2014 to 2019

    7.4.6 Vietnam Gene Therapy Consumption Volume from 2014 to 2019

    8 India Gene Therapy Market Analysis

    8.1 Consumption and Value Analysis

    8.2 Consumption Volume by Type

    8.3 Consumption Structure by Application

    9 Brazil Gene Therapy Market Analysis

    9.1 Consumption and Value Analysis

    9.2 Consumption Volume by Type

    9.3 Consumption Structure by Application

    10 GCC Countries Gene Therapy Market Analysis

    10.1 Consumption and Value Analysis

    10.2 Consumption Volume by Type

    10.3 Consumption Structure by Application

    10.4 Consumption Volume by Major Countries

    10.4.1 Consumption Volume from 2014 to 2019

    10.4.3 Qatar Gene Therapy Consumption Volume from 2014 to 2019

    10.4.4 Bahrain Gene Therapy Consumption Volume from 2014 to 2019

    11 Manufacturers Profiles

    11.6.1 Business Overview

    12 Marketing Strategy Analysis

    13 Global Gene Therapy Market Forecast (2019-2026)

    14 Research Conclusions

    15 Appendix

    15.1 Methodology

    15.2 Research Data Source

    Continued…

    Contact Us:

    Name: Mr. Ajay More

    Phone: US +1424 253 0807/ UK +44 203 239 8187

    Email id: [email protected]

    Our Other Reports:

    Rinse the Needle Market Size 2020 Top Key Players, Share, Industry Updates, Future Growth, Forthcoming Developments and Future Investments by Forecast to 2026

    Global Spray Polyurea Elastomer (SPUA) Market 2020 Industry Share Overview, Key Players, Demand, Size, Growth Factor, Trends and Forecast to 2026

    Global Cable Market 2020 Share, Top Manufacturers, Market Trends, Segmentation, Size, Growth and Competitive Landscape and Forecast to 2026

    Global Ion Exchange Membrane Market 2020 Share, Top Companies, Regional Growth Overview, CAGR Status, Size, Types and Applications and Forecast to 2026

    Global Ballistics Targeting Software Market Analysis and in-Depth Research on Market Dynamics, Industry Share, Trends, Emerging Growth Factors, CAGR Status and Market Size and Forecasts to 2026

  • Categories
    News

    Gene Therapy Market Boosting the Healthcare Industry Worldwide

    Transparency Market Research (TMR) has published a new report titled, “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global gene therapy market was valued at US$ 17.0 Mn in 2017 and is projected to expand at a CAGR of 40.0% from 2018 to 2026. New product approvals, promising therapeutic outcomes of gene therapy, and high prevalence of non-Hodgkin Lymphoma are anticipated to drive the global market in the next few years. Europe is projected to dominate the global gene therapy market, followed by U.S., by the end of 2026. Potential unmet needs in the fields of oncology, rare genetic disorders in the U.S. and Europe, new product approvals and commercialization, and high clinical R&D budgets are likely to drive the gene therapy market in these regions during the forecast period. The gene therapy market in Rest of World is projected to expand at a significant CAGR during the forecast period. The high growth rate is attributed to the anticipated approval and commercialization of gene therapy products in developed countries such as Japan, Australia & New Zealand, GCC countries, and China, and high prevalence of non-Hodgkin Lymphoma and head and neck cancers.

    Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1838

    New product approvals & commercialization drives market

    2016, 2017, and 2018 were key milestones in the history of the gene therapy market in the U.S. and Europe, as around four gene therapy products have been approved and commercialized. These products are currently in the infancy stage of commercialization, and have exhibited highly positive therapeutic outcomes. For instance, in May 2016, GlaxoSmithKline (GSK) gene therapy product, Strimvelis, received marketing approval for the treatment of patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency, due to Adenosine Deaminase deficiency). Strimvelis is the first ex-vivo stem cell gene therapy to be approved in Europe for the treatment of ADA-SCID. Furthermore, in August 2017, the USFDA approved Novartis AG’s flagship gene therapy product, Kymriah, for the treatment of children and adults up to the age of 25 years affected with B-cell precursor acute lymphoblastic leukemia (ALL). Thus, recent approvals of gene therapy products in the U.S. and Europe for the treatment of various life threatening disorders is projected to fuel the gene therapy market during the forecast period.

    Yescarta to be highest revenue generating gene therapy product

    The report offers a detailed segmentation of the global gene therapy market based on different gene therapy products approved and commercialized. Based on product, the global gene therapy market has been segmented into Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine. Yescarta (Axicabtagene Ciloleucel) is a genetically modified autologous Chimeric Antigen Receptor T (CAR T) cell immunotherapy developed by Gilead Sciences, Inc. for the treatment of adult patients with relapsed or refractory large B-cell lymphoma including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL). It is the first CAR T therapy approved by the US FDA for the treatment of DLBCL. The Yescarta segment is projected to dominate the global gene therapy market by the end of 2026. Anticipated commercialization of Yescarta in Europe and other developed countries and increasing number of treatment centers are key factors that are likely to lead to the dominant share held by Yescarta by the end of 2026.

    Request for Analysis of COVID19 Impact on Gene Therapy Markethttps://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1838

    Oncology segment to account for high market share

    In terms of application, the global gene therapy market has been segmented into ophthalmology, oncology, and adenosine deaminase ?deficient severe combined immunodeficiency (ADA-SCID). The oncology segment is likely to account for a significant share of the market by the end of 2026. Oncology is a highly studied medical field in the clinical pipeline studies of gene therapy candidates. More than 60% of gene therapy clinical research studies are focused on oncology. The large share held by the oncology segment is attributed to the approval and commercialization of Yescarta and Kymriah, in the last one to two years, for the treatment of certain types of non-Hodgkin lymphoma in the U.S. and Europe. Furthermore, increase in demand for Gendicine in China for the treatment of head and neck cancers is projected to drive the segment during the forecast period.

    Europe offers high incremental opportunity

    The gene therapy market in Europe is projected to expand at a significant CAGR of 30.6% during the forecast period. Large number of patient population with refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), promising therapeutic outcomes, rising demand for gene therapy treatment, and increasing number of gene therapy treatment centers in Europe are key factors that are likely to fuel the gene therapy market in Europe. Moreover, different pricing models are being evaluated by payers and governments to enable access to high priced gene therapy products. This is likely to drive the demand for gene therapy products in Europe during the forecast period.

    Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1838

    Large number of clinical pipeline studies and significant investments in gene therapy to gain the first mover advantage

    The global gene therapy market is highly consolidated, with very few global players accounting for a major share. Currently, only five companies; Gilead life Sciences Inc. Spark Therapeutic Inc., Novartis AG, Sibiono GeneTech Co. Ltd, and Orchard Therapeutics Limited offer gene therapy products in the market. Most biopharmaceutical companies have invested significantly in clinical R&D for the development of gene therapy products for different chronic and genetic disorders. Large number of gene therapy products are under different stages of clinical pipeline studies, and the number of gene therapy candidates is projected to rise consistently during the forecast period. For instance, according to the Journal of Gene Medicine, there were around 2,597 gene therapy candidates under clinical trials, as of 2017. Of the total clinical studies, around 65% of studies were focused on oncology, 11% of studies were focused on monogenetic field, 7% on infectious diseases and cardiovascular disease, each.

    Purchase Gene Therapy Market Reporthttps://www.transparencymarketresearch.com/checkout.php?rep_id=1838&ltype=S

    About Us

    Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

    Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

    Contact

    Transparency Market Research,

    90 Sate Street, Suite 700,

    Albany, NY 12207

    Tel: +1-518-618-1030

    USA – Canada Toll Free: 866-552-3453

    Website: https://www.transparencymarketresearch.com

    Read More Reports: https://www.prnewswire.com/news-releases/global-hemorrhoid-treatment-devices-market-to-grow-at-over-4-6-cagr-from-2018-to-2026-transparency-market-research-301001722.html

     

    Categories
    Coronavirus Market Reports News

    Gene Therapy Market: Detailed survey of the key competitors and the leading players

    According to a new report published by Polaris Market Research, the global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need.

    Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

    Request for sample copy of this report @  https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

    Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

    Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

    North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.

    Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

    Request for Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-discount-pricing

    About Polaris Market Research

    Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

    Contact us

    Mr. Likhil

    Corporate Sales, USA

    Polaris Market Research

    Phone: 1-646-568-9980

    Email: [email protected]

    Web: www.polarismarketresearch.com